Article
Optimized CRISPR-mediated gene knockin reveals FOXP3-independent maintenance of human Treg identity.
Cell reports - 3 Aug 2021
Lam Avery J, Lin David T S, Gillies Jana K, Uday Prakruti, Pesenacker Anne M, Kobor Michael S, Levings Megan K
Abstract excerpt
Regulatory T cell (Treg) therapy is a promising curative approach for a variety of immune-mediated conditions. CRISPR-based genome editing allows precise insertion of transgenes through homology-directed repair, but its use in human Tregs has been limited. We report an optimized protocol for CRISPR-mediated gene knockin in human Tregs with high-yield expansion. To establish a benchmark of human Treg dysfunction,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
